LEADER 01512nam  2200493   450 
001 9910583033803321
005 20200924011737.0
010   $a0-12-812334-6
035   $a(CKB)4100000006670311
035   $a(MiAaPQ)EBC5511117
035   $a(PPN)243625995
035   $a(EXLCZ)994100000006670311
100   $a20180927d2019      uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aAdvanced issue resolution in safety pharmacology /$fedited by Mary Jeanne Kallman, Michael K. Pugsley
210  1$aLondon, England :$cAcademic Press,$d2019.
215   $a1 online resource (435 pages)
311   $a0-12-812206-4 
606   $aPharmacology
606   $aDrug Evaluation, Preclinical
606   $aDrug-Related Side Effects and Adverse Reactions
606   $aDrug Evaluation
606   $aConsumer Product Safety
606   $aRisk Management
615  0$aPharmacology.
615 12$aDrug Evaluation, Preclinical.
615 12$aDrug-Related Side Effects and Adverse Reactions.
615 22$aDrug Evaluation.
615 22$aConsumer Product Safety.
615 22$aRisk Management.
676   $a615.1
702   $aKallman$b Mary Jeanne
702   $aPugsley$b Michael K.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910583033803321
996   $aAdvanced issue resolution in safety pharmacology$92132407
997   $aUNINA